5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.85▲ | 0.85▲ | 0.84▲ | 0.86▼ | 0.88▼ |
MA10 | 0.84▲ | 0.85▲ | 0.85▲ | 0.87▼ | 0.91▼ |
MA20 | 0.85▲ | 0.86▲ | 0.86▼ | 0.88▼ | 0.91▼ |
MA50 | 0.87▼ | 0.87▼ | 0.87▼ | 0.91▼ | 1.01▼ |
MA100 | 0.87▼ | 0.89▼ | 0.92▼ | 0.90▼ | 1.03▼ |
MA200 | 0.91▼ | 0.90▼ | 0.91▼ | 0.98▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.000▼ | -0.002▼ | -0.003▼ | 0.000▲ |
RSI | 51.718▲ | 50.190▲ | 49.087▼ | 41.866▼ | 44.498▼ |
STOCH | 49.974 | 33.386 | 26.776 | 30.136 | 36.976 |
WILL %R | -39.185 | -39.185 | -39.185 | -85.627▼ | -80.972▼ |
CCI | 31.944 | 23.441 | -8.684 | -137.931▼ | -95.310 |
Friday, April 25, 2025 05:00 PM
Summit Hotel Properties Stock Performance NYSE INN opened at $3.97 on Friday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 1.01. The stock has a ...
|
Monday, April 21, 2025 05:19 AM
IMUNON (IMNN) announced that an abstract highlighting new, highly encouraging, Overall Survival data from the Phase 2 OVATION 2 Study of ...
|
Monday, April 21, 2025 12:05 AM
IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that an abstract highlighting new, highly encouraging, Overall Survival ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.83 | 0.86 | 0.83 | 0.84 | 54,655 |
30/04/25 | 0.86 | 0.874 | 0.82 | 0.84 | 85,218 |
29/04/25 | 0.87 | 0.884 | 0.87 | 0.884 | 48,520 |
28/04/25 | 0.86 | 0.869 | 0.8501 | 0.86 | 15,773 |
25/04/25 | 0.90 | 0.90 | 0.87 | 0.8775 | 28,515 |
24/04/25 | 0.85 | 0.8962 | 0.832 | 0.8962 | 31,466 |
23/04/25 | 0.886 | 0.9079 | 0.86 | 0.8766 | 52,504 |
22/04/25 | 0.88 | 0.90 | 0.87 | 0.872 | 38,192 |
21/04/25 | 0.88 | 0.98 | 0.85 | 0.8885 | 53,593 |
17/04/25 | 0.8556 | 0.89 | 0.8165 | 0.89 | 75,910 |
|
|
||||
|
|
||||
|
|